X-ray sequence and crystal structure of luffaculin 1, a novel type 1 ribosome-inactivating protein
详细信息    查看全文
  • 作者:Xiaomin Hou (1) (2)
    Minghuang Chen (1) (2)
    Liqing Chen (3)
    Edward J Meehan (3)
    Jieming Xie (4)
    Mingdong Huang (1) (2)
  • 刊名:BMC Structural Biology
  • 出版年:2007
  • 出版时间:December 2007
  • 年:2007
  • 卷:7
  • 期:1
  • 全文大小:2305KB
  • 参考文献:1. Liang SP: Techniques of protein sequencing at the turn of the centuries. / Chinese Bulletin of Life Sciences 1999,11(1):31-5.
    2. Chambery A, de Donato A, Bolognesi A, Polito L, Stirpe F, Parente A: Sequence determination of lychnin, a type 1 ribosome-inactivating protein from Lychnis chalcedonica seeds. / Biological chemistry 2006,387(9):1261-266. CrossRef
    3. Hogg T, Kuta Smatanova I, Bezouska K, Ulbrich N, Hilgenfeld R: Sugar-mediated lattice contacts in crystals of a plant glycoprotein. / Acta Crystallogr D Biol Crystallogr 2002,58(Pt 10 Pt 1):1734-739. CrossRef
    4. Gan JH, Yu L, Wu J, Xu H, Choudhary JS, Blackstock WP, Liu WY, Xia ZX: The three-dimensional structure and X-ray sequence reveal that trichomaglin is a novel S-like ribonuclease. / Structure 2004,12(6):1015-025. CrossRef
    5. Barbieri L, Battelli MG, Stirpe F: Ribosome-inactivating proteins from plants. / Biochim Biophys Acta 1993,1154(3-):237-82.
    6. Stirpe F, Barbieri L: Ribosome-inactivating proteins up to date. / FEBS Lett 1986,195(1-):1-. CrossRef
    7. Damme EJMV, Hao Q, Chen Y, Barre A, Vandenbussche F, Desmyter S, Rougé P, Peumans WJ: Ribosome-Inactivating Proteins: A Family of Plant Proteins That Do More Than Inactivate Ribosomes. / Critical Reviews in Plant Sciences 2001,20(5):395-65.
    8. Pan KZ, Lin YJ, Zhou KJ, Fu ZJ, Chen MH, Huang DR, Huang DH: The crystal and molecular structure of trichosanthin at 2.6 A resolution. / Sci China B 1993,36(9):1069-081.
    9. Stirpe F, Barbieri L, Battelli MG, Falasca AI, Abbondanza A, Lorenzoni E, Stevens WA: Bryodin, a ribosome-inactivating protein from the roots of Bryonia dioica L. (white bryony). / Biochem J 1986,240(3):659-65.
    10. Husain J, Tickle IJ, Wood SP: Crystal structure of momordin, a type I ribosome inactivating protein from the seeds of Momordica charantia. / FEBS Lett 1994,342(2):154-58. CrossRef
    11. Yuan YR, He YN, Xiong JP, Xia ZX: Three-dimensional structure of beta-momorcharin at 2.55 A resolution. / Acta Crystallogr D Biol Crystallogr 1999, 55 (Pt 6):1144-151. CrossRef
    12. Masahiro K, Hiromi N, Gunki F: Isolation and Characterization of Two Luffins, Protein-biosynthesis Inhibitory Proteins from the seeds of Luffa cylindrica. / Agric Biol Chem 1988,52(5):1223-227.
    13. Chen MH, Ye XM, Cai JH, Lin YJ: Crystallization and preliminary crystallographic study of cucurmosin, a ribosome-inactivating protein from the sarcocarp of Cucurbita moschata. / Acta Crystallogr D Biol Crystallogr 2000, 56 (Pt 5):665-66.
    14. Rutenber E, Katzin BJ, Ernst S, Collins EJ, Mlsna D, Ready MP, Robertus JD: Crystallographic refinement of ricin to 2.5 A. / Proteins 1991,10(3):240-50. CrossRef
    15. Tahirov TH, Lu TH, Liaw YC, Chen YL, Lin JY: Crystal structure of abrin-a at 2.14 A. / J Mol Biol 1995,250(3):354-67. CrossRef
    16. Chaudhry B, Muller-Uri F, Cameron-Mills V, Gough S, Simpson D, Skriver K, Mundy J: The barley 60 kDa jasmonate-induced protein (JIP60) is a novel ribosome-inactivating protein. / Plant J 1994,6(6):815-24. CrossRef
    17. Jin YC: Intra-amniotic injection of crystal trichosanthin for induction of labour in second trimester pregnancy. / Shengzhi Yu Biyun 1985,5(1):15-7, 20.
    18. Leah R, Tommerup H, Svendsen I, Mundy J: Biochemical and molecular characterization of three barley seed proteins with antifungal properties. / J Biol Chem 1991,266(3):1564-573.
    19. Bolognesi A, Polito L: Immunotoxins and other conjugates: pre-clinical studies. / Mini Rev Med Chem 2004,4(5):563-83.
    20. Pastan II, Kreitman RJ: Immunotoxins for targeted cancer therapy. / Adv Drug Deliv Rev 1998,31(1-):53-8. CrossRef
    21. Au TK, Collins RA, Lam TL, Ng TB, Fong WP, Wan DC: The plant ribosome inactivating proteins luffin and saporin are potent inhibitors of HIV-1 integrase. / FEBS Lett 2000,471(2-):169-72. CrossRef
    22. Wang JH, Nie HL, Tam SC, Huang H, Zheng YT: Anti-HIV-1 property of trichosanthin correlates with its ribosome inactivating activity. / FEBS Lett 2002,531(2):295-98. CrossRef
    23. Parikh BA, Tumer NE: Antiviral activity of ribosome inactivating proteins in medicine. / Mini Rev Med Chem 2004,4(5):523-43.
    24. Wang P, Tumer NE: Virus resistance mediated by ribosome inactivating proteins. / Adv Virus Res 2000, 55:325-55. CrossRef
    25. Lin JK, Chen MH, Xie JM, Zhao R, Ye XM, Shi XL, Wang ZR: Purification and Characterization of Two Luffaculins, Ribosome-inactivating Proteins from Seeds of Luffa acutangula. / Chinese Journal of Biochemistry and Molecular Biology 2002,18(5):609-13.
    26. Chen MH, Shi XL, Ye XM, Xie JM, Zhao R, Rao PF, Wang ZR: Study on the secondary structure and bioactivities of Luffaculin 1. / Chinese J Struct Chem 2004, 23:232-35.
    27. Zhao R, Xie JM, Xu JH, Chen MH, Lin JK, Ye XM: Apoptosis-inducing effect of luffaculin on K562 cells. / Pharmacology and Clinics of Chinese Materia Medica 2001,17(6):24-6.
    28. XIE JM, Chen MH, Xu Y, Zhao R, Xu JH, Yu ZX: Differentiation-inducing effect of Luffaculin-1 on B16 melanoma cells. / Chin J Cancer Prev Treat 2005,12(20):1521-524.
    29. Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM: AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. / J Biomol NMR 1996,8(4):477-86. CrossRef
    30. Savino C, Federici L, Ippoliti R, Lendaro E, Tsernoglou D: The crystal structure of saporin SO6 from Saponaria officinalis and its interaction with the ribosome. / FEBS Lett 2000,470(3):239-43. CrossRef
    31. Rudd PM, Wormald MR, Stanfield RL, Huang M, Mattsson N, Speir JA, DiGennaro JA, Fetrow JS, Dwek RA, Wilson IA: Roles for glycosylation of cell surface receptors involved in cellular immune recognition. / J Mol Biol 1999,293(2):351-66. CrossRef
    32. Wormald MR, Dwek RA: Glycoproteins: glycan presentation and protein-fold stability. / Structure 1999,7(7):R155-0. CrossRef
    33. Brunger AT, Adams PD, Clore GM, DeLano WL, Gros P, Grosse-Kunstleve RW, Jiang JS, Kuszewski J, Nilges M, Pannu NS, Read RJ, Rice LM, Simonson T, Warren GL: Crystallography & NMR system: A new software suite for macromolecular structure determination. / Acta crystallographica 1998,54(Pt 5):905-21.
    34. Jones TA, Zou JY, Cowan SW, Kjeldgaard M: Improved methods for building models in electron density maps and the location of errors in these models. / Acta Crystallogr A 1991, 47:110-19. CrossRef
    35. Monzingo AF, Robertus JD: X-ray analysis of substrate analogs in the ricin A-chain active site. / J Mol Biol 1992,227(4):1136-145. CrossRef
    36. Fermani S, Falini G, Ripamonti A, Polito L, Stirpe F, Bolognesi A: The 1.4 anstroms structure of dianthin 30 indicates a role of surface potential at the active site of type 1 ribosome inactivating proteins. / Journal of structural biology 2005,149(2):204-12. CrossRef
    37. Robertus JD, Monzingo AF: The structure of ribosome inactivating proteins. / Mini Rev Med Chem 2004,4(5):477-86.
    38. Mcpherson A: Preparation and Analysis of Protein Crystals. New York , John Wiley 1982, 82-59.
    39. Otwinnowski Z, Minor W: Processing of X-ray diffraction data collected in oscillation model. / Methods Enzymol 1997, 276:307-26. CrossRef
    40. Matthews BW: Solvent content of protein crystals. / J Mol Biol 1968,33(2):491-97. CrossRef
    41. Navaza J: AmoRe-an automated package for molecular replacement. / Acta Crystallogr A 1994, 50:157-63. CrossRef
    42. Navaza J: Implementation of molecular replacement in AMoRe. / Acta Crystallogr D Biol Crystallogr 2001,57(Pt 10):1367-372. CrossRef
    43. Guex N, Peitsch MC: SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. / Electrophoresis 1997,18(15):2714-723. CrossRef
    44. Schwede T, Kopp J, Guex N, Peitsch MC: SWISS-MODEL: An automated protein homology-modeling server. / Nucleic Acids Res 2003,31(13):3381-385. CrossRef
    45. Huai Q, Mazar AP, Kuo A, Parry GC, Shaw DE, Callahan J, Li Y, Yuan C, Bian C, Chen L, Furie B, Furie BC, Cines DB, Huang M: Structure of human urokinase plasminogen activator in complex with its receptor. / Science (New York, NY 2006,311(5761):656-59.
    46. DeLano WL: The PyMOL Molecular Graphics System. [http://www.pymol.org] 2002.
  • 作者单位:Xiaomin Hou (1) (2)
    Minghuang Chen (1) (2)
    Liqing Chen (3)
    Edward J Meehan (3)
    Jieming Xie (4)
    Mingdong Huang (1) (2)

    1. State Key Laboratory of Structural Chemistry, Fujian Institute of Research on the Structure of Matter, The Chinese Academy of Sciences, 155 Yang Qiao Xi Lu, Fuzhou, Fujian, 350002, China
    2. Graduate School of Chinese Academy of Sciences, The Chinese Academy of Sciences, Beijing, 10039, China
    3. Laboratory for Structural Biology, Department of Chemistry, Graduate Programs of Biotechnology, Chemistry and Materials Science, University of Alabama in Huntsville, Huntsville, AL, 35899, USA
    4. Fujian Medical University, Fuzhou, 350004, China
  • ISSN:1472-6807
文摘
Background Protein sequence can be obtained through Edman degradation, mass spectrometry, or cDNA sequencing. High resolution X-ray crystallography can also be used to derive protein sequence information, but faces the difficulty in distinguishing the Asp/Asn, Glu/Gln, and Val/Thr pairs. Luffaculin 1 is a new type 1 ribosome-inactivating protein (RIP) isolated from the seeds of Luffa acutangula. Besides rRNA N-glycosidase activity, luffaculin 1 also demonstrates activities including inhibiting tumor cells' proliferation and inducing tumor cells' differentiation. Results The crystal structure of luffaculin 1 was determined at 1.4 ? resolution. Its amino-acid sequence was derived from this high resolution structure using the following criteria: 1) high resolution electron density; 2) comparison of electron density between two molecules that exist in the same crystal; 3) evaluation of the chemical environment of residues to break down the sequence assignment ambiguity in residue pairs Glu/Gln, Asp/Asn, and Val/Thr; 4) comparison with sequences of the homologous proteins. Using the criteria 1 and 2, 66% of the residues can be assigned. By incorporating with criterion 3, 86% of the residues were assigned, suggesting the effectiveness of chemical environment evaluation in breaking down residue ambiguity. In total, 94% of the luffaculin 1 sequence was assigned with high confidence using this improved X-ray sequencing strategy. Two N-acetylglucosamine moieties, linked respectively to the residues Asn77 and Asn84, can be identified in the structure. Residues Tyr70, Tyr110, Glu159 and Arg162 define the active site of luffaculin 1 as an RNA N-glycosidase. Conclusion X-ray sequencing method can be effective to derive sequence information of proteins. The evaluation of the chemical environment of residues is a useful method to break down the assignment ambiguity in Glu/Gln, Asp/Asn, and Val/Thr pairs. The sequence and the crystal structure confirm that luffaculin 1 is a new type 1 RIP.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700